Jasper Therapeutics Inc.

09/10/2024 | Press release | Distributed by Public on 09/10/2024 05:53

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma